These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6600257)

  • 1. Modulation of the biologic activities of IgE-binding factors. I. Identification of glycosylation-inhibiting factor as a fragment of lipomodulin.
    Uede T; Hirata F; Hirashima M; Ishizaka K
    J Immunol; 1983 Feb; 130(2):878-84. PubMed ID: 6600257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the biologic activities of IgE-binding factors. VII. Biochemical mechanisms by which glycosylation-enhancing factor activates phospholipase in lymphocytes.
    Akasaki M; Iwata M; Ishizaka K
    J Immunol; 1985 Jun; 134(6):4069-77. PubMed ID: 3872909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of IgE-binding factors by rat T lymphocytes. VI. Cellular mechanisms for the formation of IgE-potentiating factor and IgE-suppressive factor by antigenic stimulation of antigen-primed spleen cells.
    Uede T; Ishizaka K
    J Immunol; 1982 Oct; 129(4):1391-7. PubMed ID: 6980933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the biologic activities of IgE-binding factors. III. Switching of a T cell hybrid clone from the formation of IgE-suppressive factor to the formation of IgE-potentiating factor.
    Huff TF; Uede T; Iwata M; Ishizaka K
    J Immunol; 1983 Sep; 131(3):1090-5. PubMed ID: 6224847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the biologic activities of IgE binding factor. VI. The activation of phospholipase by glycosylation enhancing factor.
    Iwata M; Akasaki M; Ishizaka K
    J Immunol; 1984 Sep; 133(3):1505-12. PubMed ID: 6431000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the biologic activities of IgE-binding factor. V. The role of glycosylation-enhancing factor and glycosylation-inhibiting factor in determining the nature of IgE-binding factors.
    Iwata M; Huff TF; Ishizaka K
    J Immunol; 1984 Mar; 132(3):1286-93. PubMed ID: 6363537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory role of IgE-binding factors from rat T lymphocytes. IV. Formation of IgE-binding factors in rats treated with complete Freund's adjuvant.
    Hirashima M; Yodoi J; Ishizaka K
    J Immunol; 1980 Nov; 125(5):2154-60. PubMed ID: 6968774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor.
    Uede T; Ishizaka K
    J Immunol; 1984 Jul; 133(1):359-67. PubMed ID: 6609987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1984 Dec; 133(6):3266-73. PubMed ID: 6208275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of IgE-binding factors by rat T lymphocytes. V. Effect of adjuvant for the priming immunization on the nature of IgE binding factors formed by antigenic stimulation.
    Uede T; Huff TF; Ishizaka K
    J Immunol; 1982 Oct; 129(4):1384-90. PubMed ID: 6980932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes bearing Fc receptors for IgE. VI. Suppressive effect of glucocorticoids on the expression of Fc epsilon receptors and glycosylation of IgE-binding factors.
    Yodoi J; Hirashima M; Ishizaka K
    J Immunol; 1981 Aug; 127(2):471-6. PubMed ID: 6972964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.
    Akasaki M; Jardieu P; Ishizaka K
    J Immunol; 1986 May; 136(9):3172-9. PubMed ID: 2937840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc epsilon receptors on T and B lymphocytes.
    Huff TF; Yodoi J; Uede T; Ishizaka K
    J Immunol; 1984 Jan; 132(1):406-12. PubMed ID: 6197453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.
    Steele JK; Kuchroo VK; Kawasaki H; Jayaraman S; Iwata M; Ishizaka K; Dorf ME
    J Immunol; 1989 Apr; 142(7):2213-20. PubMed ID: 2466892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes bearing Fc receptors for IgE. V. Effect of tunicamycin on the formation of IgE-potentiating factor and IgE-suppressive factor by con A-activated lymphocytes.
    Yodoi J; Hirashima M; Ishizaka K
    J Immunol; 1981 Mar; 126(3):877-82. PubMed ID: 6970224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes.
    Yodoi J; Ishizaka K
    J Immunol; 1980 Mar; 124(3):1322-9. PubMed ID: 6965690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of IgE-binding factors by rat T lymphocytes. III. Mechanisms of selective formation of IgE-suppressive factors by treatment with complete Freund's adjuvant.
    Hirashima M; Yodoi J; Huff TF; Ishizaka K
    J Immunol; 1981 Nov; 127(5):1810-6. PubMed ID: 6975298
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory role of IgE-binding factors from rat T lymphocytes. II. Glycoprotein nature and source of IgE-potentiating factor.
    Yodoi J; Hirashima M; Ishizaka K
    J Immunol; 1980 Oct; 125(4):1436-41. PubMed ID: 6967902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. III. Suppressive factor of allergy (SFA) is produced during the in vitro FcR epsilon expression cascade and displays corollary physiologic activity in vivo.
    Marcelletti JF; Katz DH
    J Immunol; 1984 Dec; 133(6):2837-44. PubMed ID: 6238086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.